AI Assistant
Blog
Pricing
Log In
Sign Up
TAVI likely to be a cost-effective option for SAVR-ineligible patients with severe aortic stenosis
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
